Study Stopped
The study was terminated because the preliminary data did not indicate efficacy.
Thigh Circumference Reduction Study
Cutera Radio Frequency Device for Thigh Circumference Reduction
1 other identifier
interventional
4
1 country
1
Brief Summary
The purpose of this study is to evaluate the Cutera radio frequency (RF) device for the new indication of reduction of thigh circumference.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2009
CompletedFirst Submitted
Initial submission to the registry
August 4, 2009
CompletedFirst Posted
Study publicly available on registry
August 6, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2010
CompletedResults Posted
Study results publicly available
April 18, 2011
CompletedMay 10, 2011
May 1, 2011
1 year
August 4, 2009
February 17, 2011
May 6, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Difference in Circumference of Upper Thigh Between Treated and Untreated Control Arms
Mean difference of change from baseline between two arms: \[Treated arm - Untreated arm\]
Baseline and 6 months post final treatment
Difference in Circumference of Mid Thigh Between Treated and Untreated Control Arms
Mean difference of change from baseline between two arms: \[Treated arm - Untreated arm\]
Baseline and 6 months post final treatment
Secondary Outcomes (2)
Subject Satisfaction
Baseline and 6 months post final treatment
Adverse Events
At each visit (treatment and follow-up) or until resolution of AEs
Study Arms (2)
Treated Thigh
EXPERIMENTALThe thigh treated with the RF device
Untreated Thigh
NO INTERVENTIONThe untreated thigh
Interventions
Up to three treatments, one pass, dosage range of 15-60 kJ.
Eligibility Criteria
You may qualify if:
- Body Mass Index between 20 and 35
- Presence of cellulite grades II, III or IV according to GLD scale
- Visible bi-lateral thigh fat Thigh area to be treated to measure at least 30.0mm in vertical fold, as measured with industry standard fat caliper
- Subject must be able to read, understand and sign the Consent Form
- Subject must adhere to the follow-up schedule and study instructions
- Subject must adhere to the same diet and/or exercise routine throughout the study
You may not qualify if:
- Significant weight fluctuation (+/-10 lbs) in the past 6 months
- Taking weight-loss medications/supplements
- Participation in any other clinical study
- Cellulite treatment within 3 months of the treatment
- Surgical or non-surgical treatments to the target area in the last 12 months, e.g., liposuction
- Prior treatment to the target area within the last 12 months
- Arteriosclerosis or weakened blood vessels
- Heart disease
- Thromboembolic disease
- Diagnosed or documented immune system disorders
- Bleeding disorders.
- Presence of uncontrolled hypertension
- Taking prescription anticoagulants
- History of keloid formation
- Malignant tumors in the target area
- +6 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cutera Inc.lead
Study Sites (1)
Blackhawk Plastic Surgery
Danville, California, 94506, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Early termination of the study resulting in analysis of small numbers of subjects, and technical issues with repeatability and reproducibility of circumference measurements leading to termination.
Results Point of Contact
- Title
- Ayse Turley, Clinical Development Researcher
- Organization
- Cutera Inc.
Study Officials
- PRINCIPAL INVESTIGATOR
Stephen J. Ronan, MD
- PRINCIPAL INVESTIGATOR
Jacqueline Calkin, MD
- PRINCIPAL INVESTIGATOR
Christine Lee, MD
- PRINCIPAL INVESTIGATOR
Scott Kramer, MD
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
August 4, 2009
First Posted
August 6, 2009
Study Start
January 1, 2009
Primary Completion
January 1, 2010
Study Completion
January 1, 2010
Last Updated
May 10, 2011
Results First Posted
April 18, 2011
Record last verified: 2011-05